Changes in myocardial connexin 43 during ventricular fibrillation

Chinese Critical Care Medicine

Volumn 22, Issue 10, 2010, Pages 595-598

  Liu, Hong Zhen ^a   Zhong, Jing Quan ^a   Li, Jing Sha ^a   Su, Guo Ying ^a   Wang, Jing ^a   Zhang, Yun ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Connexin 43; Rotigaptide; Ventricular fibrillation

Indexed keywords

CONNEXIN 43;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DOWN REGULATION; HEART VENTRICLE FIBRILLATION; IMMUNOFLUORESCENCE; NONHUMAN; PROTEIN EXPRESSION; WESTERN BLOTTING;

ANIMALS; CONNEXIN 43; DISEASE MODELS, ANIMAL; MYOCARDIUM; OLIGOPEPTIDES; SWINE; VENTRICULAR FIBRILLATION;

EID: 78649377546     PISSN: 10030603     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.1003-0603.2010.10.007     Document Type: Article

References (13)

1. Hervé JC, Dhein S. Pharmacology of cardiovascular gap junctions. Adv Cardiol,2006,42:107-131. (Pubitemid 43805860)
2. Goodenough DA, Goliger JA, Paul DL. Connexins, connexons, and intercellular communication. Annu Rev Biochem,1996,65:475-502.
3. Weidmann S. The diffusion of radiopotassium across intercalated disks of mammalian cardiac muscle. J Physiol,1966,187:323-342.
4. Kojodjojo P, Kanagaratnam P, Segal OR, et al. The effects of carbenoxolone on human myocardial conduction: a tool to investigate the role of gap junctional uncoupling in human arrhythmogenesis. J Am Coll Cardiol,2006,48:1242-1249.
5. Peters NS, Coromilas J, Severs NJ, et al. Disturbed connexin 43 gap junction distribution correlates with the location of reentrant circuits in the epicardial border zone of healing canine infarcts that cause ventricular tachycardia. Circulation,1997,95:988-996.
6. Lerner DL, Yamada KA, Schuessler RB, et al. Accelerated onset and increased incidence of ventricular arrhythmias induced by ischemia in Cx43-deficient mice. Circulation,2000, 101:547-552.
7. KjΦlbye AL, Haugan K, Hennan JK, et al. Pharmacological modulation of gap junction function with the novel compound rotigaptide: a promising new principle for prevention of arrhythmias. Basic Clin Pharmacol Toxicol,2007,101:215-230.
8. Xing D, KjΦlbye AL, Petersen JS, et al. Pharmacological stimulation of cardiac gap junction coupling does not affect ischemia-induced focal ventricular tachycardia or triggered activity in dogs. Am J Physiol Heart Circ Physiol,2005,288:H511-516.
9. Haugan K, Olsen KB, Hartvig L, et al. The antiarrhythmic peptide analog ZP123 prevents atrial conduction slowing during metabolic stress. J Cardiovasc Electrophysiol,2005,16:537-545. (Pubitemid 40632487)
10. Xing D, KjΦlbye AL, Nielsen MS, et al. ZP123 increases gap junctional conductance and prevents reentrant ventricular tachycardia during myocardial ischemia in open chest dogs. J Cardiovasc Electrophysiol,2003,14:510-520.
11. Stahlhut M, Petersen JS, Hennan JK, et al. The anti-arrhythmic peptide rotigaptide (ZP123) increases connexin 43 protein expression in neonatal rat ventricular cardiomyocytes. Cell Commun Adhes,2006,13:21-27.